266
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus

, &
Pages 560-568 | Received 28 Apr 2020, Accepted 14 May 2020, Published online: 01 Jun 2020
 

Abstract

Background

Photodynamic therapy (PDT) is an alternative treatment modality for vulvar lichen sclerosus (VLS) which is a chronic inflammatory mucosal condition. In literature, no consensus of optimal parameters of PDT for VLS is reached so far.

Objectives

The aim of this narrative review is to develop a standardized treatment protocol for PDT in VLS.

Methods

A systematic literature search was conducted to identify studies reporting on PDT in VLS and used treatment parameters, side-effects, and clinical outcomes were summarized.

Results

Thirteen studies used 5-aminolevulinic acid (5-ALA) with concentrations of 20%, 10%, 5% and three studies used methyl aminolevulinate (MAL). Generally, the light source was red light (median 630 nm). Light dose varied between 9 and 180 J/cm2 and light intensity between 40 and 700 mW/cm2. Incubation period with the photosensitizer ranged from 2 to 6 h. All studies showed a substantial improvement in VLS-related pruritus, burning and pain.

Conclusions

Based on a literature review, we suggest the following protocol for PDT in VLS: 5% 5-ALA as a photosensitizer applied for 3 h under occlusion before irradiation at the dose of 120 J/cm2 with red light (590–760 nm) and intensity of 204 mW/cm2.

Acknowledgments

The authors thank Thomas Vandendriessche, Magdalena Jans and Krizia Tuand, the biomedical reference librarians of the KU Leuven Libraries – 2Bergen – learning Center Désiré Collen (Leuven, Belgium) for their help with setting up valid and sound search terms.

Disclosure statement

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.